Viveve Medical Inc
Viveve develops and sells healthcare-focused human resources (HR) software solutions designed to streamline and unify HR operations for healthcare organizations. It offers an all-in-one platform that supports recruitment, employee management, and attendance management, aiming to reduce administrative burden and enhance the employee experience throughout their career lifecycle. The company also pr… Read more
Market Cap & Net Worth: Viveve Medical Inc (VIVE)
Viveve Medical Inc (PINK:VIVE) has a market capitalization of $2.14K ($2.14K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #47218 globally and #14634 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Viveve Medical Inc's stock price $0.00 by its total outstanding shares 10723857 (10.72 Million).
Viveve Medical Inc Market Cap History: 2015 to 2025
Viveve Medical Inc's market capitalization history from 2015 to 2025. Data shows change from $72.49 Billion to $2.14K (-84.14% CAGR).
Viveve Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Viveve Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.90x
Viveve Medical Inc's market cap is 1.90 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $72.49 Billion | $1.45 Million | -$12.43 Million | 50099.01x | N/A |
| 2016 | $55.23 Billion | $7.14 Million | -$20.11 Million | 7733.91x | N/A |
| 2017 | $53.30 Billion | $15.29 Million | -$36.63 Million | 3486.24x | N/A |
| 2018 | $11.26 Billion | $18.52 Million | -$49.18 Million | 608.09x | N/A |
| 2019 | $135.12 Million | $6.57 Million | -$42.53 Million | 20.58x | N/A |
| 2020 | $50.40 Million | $5.48 Million | -$21.91 Million | 9.20x | N/A |
| 2021 | $12.23 Million | $6.43 Million | -$22.03 Million | 1.90x | N/A |
Competitor Companies of VIVE by Market Capitalization
Companies near Viveve Medical Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Viveve Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Viveve Medical Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Viveve Medical Inc's market cap moved from $72.49 Billion to $ 2.14K, with a yearly change of -84.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.14K | -50.00% |
| 2024 | $4.29K | +100.00% |
| 2023 | $2.14K | -99.95% |
| 2022 | $4.56 Million | -62.72% |
| 2021 | $12.23 Million | -75.74% |
| 2020 | $50.40 Million | -62.70% |
| 2019 | $135.12 Million | -98.80% |
| 2018 | $11.26 Billion | -78.87% |
| 2017 | $53.30 Billion | -3.50% |
| 2016 | $55.23 Billion | -23.82% |
| 2015 | $72.49 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Viveve Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.14K USD |
| MoneyControl | $2.14K USD |
| MarketWatch | $2.14K USD |
| marketcap.company | $2.14K USD |
| Reuters | $2.14K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.